We are proud to work with an integrated group of individuals from various backgrounds and experiences. TRIANA Biomedicines is a venture-backed biopharmaceutical company leading a transformative approach to discover and develop novel therapeutics to treat diseases. These innovative “molecular glues” allow us to treat diseases in entirely new ways, by pursuing highly relevant disease targets that have long been considered undruggable or are inadequately addressed. Our initial focus on targeted protein degradation (TPD) is driven by our desire to discover and develop groundbreaking new cancer medicines. Our creativity and dedication are the glue that unites us in pursuit of our mission. Trojer brings 20+ years of experience in transcription and chromatin regulation and 15+ years of drug discovery and oncology experience to TRIANA. Chen joined RA Capital Management in 2019 as an entrepreneur-in-residence and co-founded TRIANA Biomedicines and Avilar Therapeutics. Valentine is the Founder of KHV Advisory, LLC.
This company is:
Keywords
Industries
Where is TRIANA Biomedicines located?
The company TRIANA Biomedicines is located in Waltham, Massachusetts, United States. It's worth noting that the company may has more corporate locations
How many employees does TRIANA Biomedicines approximately have?
As of the latest available information TRIANA Biomedicines has around 11-50 employees worldwide.
In which industries does TRIANA Biomedicines mainly work?
The company TRIANA Biomedicines has it's main focus in the industries of Biotechnology
T-Cypher Bio
United Kingdom
1-10 Employees
2020
View
Transition Bio
United States
1-10 Employees
View
Therini Bio
United States
1-10 Employees
2016
View
Abata Therapeutics
United States
51-100 Employees
2021
View
Affini-T Therapeutics
United States
51-100 Employees
View
Treventis
Canada
11-50 Employees
2008
View
Innova Therapeutics
United States
1-10 Employees
View
Parthenon Therapeutics
United States
11-50 Employees
2019
View
Topics which have been searched by others and may be interesting for you: